Regulatory Due Diligence for Deals in India

Regulatory diligence answers two questions the commercial case takes for granted: is the target permitted to run the business it runs, and is the deal you have structured permitted to complete. The first is about the target's own licences and its standing with the regulators that grant them. The second is about the approvals the transaction itself must obtain before ownership can change. Both are matters of the regulatory record and the statute, not management comfort, and either can reprice the deal or become a condition to closing.

This is deliberately distinct from the legal and ESG streams that run beside it. Legal diligence reads the company's contracts, title and litigation; ESG diligence reads its environmental and social footprint. Regulatory diligence reads the sector permissions the business trades on and the clearances the deal must clear. Gladwin scopes each thread, sequences it against the deal timetable on our due diligence desk, and coordinates the regulatory and legal specialists who execute the detailed review and hold the specialist opinion.

The point of regulatory diligence in India is the density of the regime. A single target can answer to several regulators at once, each with its own licence, its own change-of-control gate and its own idea of a fit-and-proper owner. An NBFC or fintech engages the RBI; an insurer answers to IRDAI; a pharma manufacturer needs CDSCO and DCGI approvals; a telecom operator sits under DoT and TRAI; a food business is licensed by FSSAI; a market intermediary is registered with SEBI. Each of these regulators can hold a prior-approval right over a transfer of control, and each attaches conditions to the licence that a change of ownership can breach.

Layered on top is the transaction's own clearance map. A deal above the thresholds is notifiable to the Competition Commission of India and cannot close until it clears. A regulated financial entity often needs the RBI's prior approval for a change in control or shareholding. A cross-border acquisition must sit inside the FDI sectoral cap, take the automatic or government-approval route the applicable press note prescribes, and comply with FEMA pricing and reporting. Environmental clearances and consents to operate can gate site-dependent operations. Read together, these permissions form a critical path, and the length and certainty of that path is often the real constraint on the deal timeline.

A regulatory finding is only useful when it lands on price, a condition precedent, a covenant or the timetable. Gladwin integrates the regulatory stream with the financial, legal, commercial and other workstreams so that a required CCI notification becomes a scheduled condition to closing, a non-transferable licence becomes a pre-completion obligation or a restructured deal step, and an unresolved show-cause notice becomes a specific indemnity with a quantified ceiling. The output is one prioritised red-flag report that ties each regulatory issue to its commercial and timing consequence.

That integration is where the regulatory stream connects to the wider mandate. The approval map feeds the conditions precedent, the standstill and long-stop provisions and the completion mechanics in the SPA, and it runs through our M&A transaction advisory desk so that the regulatory critical path, the deal structure and the negotiated timetable move together. Where a change of control also reshapes the leadership and governance the regulator relies on, the findings inform the wider mandate and, where relevant, our leadership assessment and interim leadership deployment work.